PIEZO1 and liver disorder: Piezo1’s pleiotropic roles in cancer reflect tissue-specific mechanotransduction programs: pro-fibrotic/pro-tumorigenic in liver diseases, yet tumor-suppressive in NSCLC and gastric cancer.